Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - misoprostol, quantity: 200 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; hydrogenated castor oil; microcrystalline cellulose; hypromellose - cytotec is indicated in the treatment of acute duodenal and gastric ulcers. cytotec is indicated for the prevention of stress-induced upper gastrointestinal mucosal bleeding and lesions in post-surgical patients in intensive care units. cytotec is indicated for the prevention of gastric ulceration in patients in whom nsaid therapy is essential and who have been assessed at high risk of gastric ulceration, or the complications of gastric ulceration.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - quinagolide hydrochloride, quantity: 0.0819 mg (equivalent: quinagolide hydrochloride, qty 75 microgram) - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; hypromellose; maize starch; microcrystalline cellulose; lactose monohydrate - hyperprolactinaemia (idiopathic or originating from a prolactin- secreting pituitary microadenoma or macroadenoma) associated with its clinical manifestations such as galactorrhoea, oligomenorrhoea, amenorrhoea, infertility and reduced libido.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mundipharma pharmaceuticals sdn. bhd. - fluticasone propionate; formoterol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - dutasteride, quantity: 500 microgram; tamsulosin hydrochloride, quantity: 400 microgram - capsule, modified release - excipient ingredients: maize starch; carrageenan; gelatin; purified talc; butylated hydroxytoluene; iron oxide yellow; titanium dioxide; iron oxide red; glycerol; medium chain triglycerides; potassium chloride; microcrystalline cellulose; methacrylic acid - ethyl acrylate copolymer (1:1); purified water; triethyl citrate; lecithin; glyceryl caprylate/caprate; sunset yellow fcf; carnauba wax; hypromellose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - doubluts is indicated for the management of moderate to severe symptomatic benign prostatic hyperplasia (bph).

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: microcrystalline cellulose; polyethylene oxide; magnesium stearate - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: magnesium stearate; polyethylene oxide; microcrystalline cellulose - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: polyethylene oxide; magnesium stearate; microcrystalline cellulose - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tamsulosin hydrochloride, quantity: 400 microgram - tablet, modified release - excipient ingredients: quinoline yellow; purified talc; polyethylene oxide; cochineal; microcrystalline cellulose; magnesium stearate; hyprolose; butylated hydroxytoluene; macrogol 400; titanium dioxide; iron oxide black; hypromellose; colloidal anhydrous silica - for the relief of lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph).